Lectins, a group of specific glycoproteins present in animal as well as plant cells, are used as differentiating markers to study cancers and metastatic cell lines. This property of lectins depends on the process of cellular glycosylation. Glycosylation of some of the extracellular membrane proteins and lipids maintains the cell/cell and cell/matrix interactions. Chemical alterations in glycosylation play an important role in the metastatic behavior of tumor cells. Carbohydrate residues of the membrane glycoproteins can be detected using lectins due to their binding specificity to carbohydrates. Lectins, therefore have gained an importance in the field of cancer research. Galectins, a specialized group of lectin like proteins that are Ca+ independent and galactoside binding, are also considered as differentiation markers in some specific cancers like the carcinomas of thyroid.
INTRODUCTION
Cell division and differentiation of a single cell leads to the multicellularity and adulthood. Any change or aberration in this regulatory system of cell division and differentiation may lead to autonomous cell multiplicity giving rise to malignancy defining a cancerous/ neoplastic growth. The common neoplasms of breast cancer, lung cancer and colon cancer are a challenge in both the developed as well as developing countries of 20 = century. In United States mortality associated with lung and bronchus cancer among women continues to increase and lung cancer is expected to account for 25% of all female cancer deaths in the year2000 (1) . Increased mortality rate due to cancer is also reported from vadous developing countries like Singapore (2), India (3), Thailand (4) etc.
Despite this degree of penetrance, cancer therapy
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is not successful mainly due to the lack of appropriate treatment once the cancer has spread. The formation of metastasis and it's proliferation, i.e., migration of neoplastic cells to different body parts via blood stream and lymph channels, is therefore most important in determining the fate of cancer patients. The process of metastasis formation is multistep (5) and each step involves cell to cell and cell to matrix interactions (6) . Hence to understand and contmlthis proliferative disease, new investigations have recently been shifted to these interactions (6) . As both the outer surfaces of the cell membrane and the extra cellular matrix consist mainly of glycoconjugates, altered carbohydrate residues of these membrane glycoproteins due to neoplastic invasion can be detected using protein markers like lectins. This could create new insight into the process governing the metastatic cascade (6) . In a study, inhibition of proliferation and induction of differentiation ofglioma cells was found with a plant lectin, Datura stramonium agglutinin suggesting that this lectin may be useful as a newtherapy for treating glioma without side effects (7) . Modem research in this area showing some promising results is thus related to glycoproteins and lectins. Biochemistry, 2003, 18 (2) Lectins are indigenously faund proteins or glycoproteins that are known for their c~arbohydrate binding specificities (8) . This binding property makes them remarkable markers that are used in the studies involving histochemical, biochemical and functional techniques to characterize and differentiate cancer cells. In this review histochemically worked out lectin specificity to various carcinomas is taken into account using clinical material.
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HISTOCHEMICAL IDENTIFICATION OF LECTINS:
Tumors dedved from epithelial tissues showing glandular differentiation (tumor of colon, breast and female genetalia) are mostly used for the study of lectin histochemistry. Neoplasias of human breast and colon are mainly used to study the histochemical behavior of a plant lectin leukoagglutinin (L-PHA) and it was found that L-PHA-reactive beta 1-6 branched N-linked oligosacchaddes are consistently increased in neoplasias of human breast and colon and that the level of L-PHA staining correlates with the pathological staging of the diseases (9).
Glands are differentiated as serous and mucous by analyzing their secretary product. Serous glands are negative for general carbohydrate stain and the Periodic Acid Schiff's reagent (PAS) reaction, while mucous glands are PAS positive. Their lectin binding pattems also reflect this property. Accordingly, lectins that recognize the N-linked sugars in the cell membrane glycocalyx bind with serous glandular cells. Such lectins include Concanavalin-A (Con A), Phytohaemagglutinin-L (PHA-L) etc. On the other hand lectins that identify O-linked glycoprotein bind to mucous cells. These lectins are either Nacetylgalactosamine specific (Soyabean agglutinin-SBA, Do/ichos biflorus agglutinin-DBA and Helix pomatia agglutinin-HPA) or Fucose specific (Ulex europaeusagglutinin-UEA-I) ( Table 1) . Cell surface carbohydrate chains of human germ cell tumors were investigated histochemically using peanut agglutinin (PNA), Do/ichos biflorus agglutinin (DBA), U/ex europaeus agglutinin-I (UEA-1), and anti-(Ma) antibody. Peanut agglutinin, a lectin specific for terminal beta-galactosyl residues, bound to the surface of tumor cells, D. biflorus agglutinin, was found to be specific for terminal alpha-N-acetyl galactosamine residues, and U. europ'aeus agglutinin, was tested to bound to terminal alpha-Lfucosyl residues (10 It has become apparent that lectins with similar carbohydrate specificities can show different pattems of reaction when applied to different tissue sections. This alteration may result due to slight differences in specificity and /or structural characteristics of the tissue glycocalyx or the lectin (11) . In tumor cells alterations in cellular glycosylation may play a key role in metastatic behavior of tumor cells. The three studied metastatic cell lines, LOX (malignant melanoma), FEMX (malignant melanoma) and MA-11 (mammary carcinoma) have a very different metastatic behavior In vivo, and different glycans have been suggested to bring about these differences (12) . Glycosytation, the most frequent biochemical alteration associated with tumorogenesis, modulates cell adhesion regulated by the integdns, the oncodevelopmental carbohydrate epitopes, which are altered in their expression as well as properties when transformation occurs. In the studied cell lines (T-24, Hu456, HCV29T-from human bladder carcinoma and HCV29, HCV29T-from human normal ureter and bladder epithelium) alpha3betal integrinswere glycosylated, although in general each subunit is glycosylated differently (13) . Positive reaction of alpha3betal integrin with Phase~lus vulgaris agglutinin and Datura stramonium agglutinin was found in cancerous cell lines (T-24, Hu456) as well as in normal bladder epithelial cells (Hu609). The changes in glycosylation profile attributed to invasive phenotype are associated with alpha3 not beta1 subunit (13 Table 2 ). This identification is proved to be very useful in detecting and distinguishing different types of adenomas and carcinomas thus to add a help in their treatment therapy.
Breast cancer specific lectins
Lectins are good markers and are well suited to the study of changes in carbohydrate expression in the development of breast cancer. Incomplete glycosylation is considered to be the cause of carbohydrate alteration. The changed expression of a carcinoma-associated carbohydrate core epitope (like Tn) could be due to blockage at the earliest steps of oligosaccharide chain synthesis (14) . Klein et al. (1981 Klein et al. ( , 1983 ) worked out the lectin histochemical association with breast cancer for the first time (15, 16) . These studies indicate that the expression of binding sites for Peanut agglutinin (PNA) in breast cancer was correlated with the steroidal hormone receptor estimation (15) . Some latter studies of breast cancer did reveal differences in lectin binding between normal and hyperplastic breast tissue and that in breast cancer (17) , PNAbinding, as a prognostic indicator was not accepted widely.
Roman snail lectin, Helix pomatia agglutinin (HPA) when tested was proved to be quite successful histochemically (Table 2) . Specific correlation between HPA-binding and axillary lymph node metastasis was reported (18, 19) and then clarified in two subsequent abstracts. Leathem.s group published two more papers (20, 21) showing a correlation between HPA-binding to breast cancer cells and patients prognosis. SCID (severe combined immunodeficient) mice were used as test systems to workout the correlation between metastatic potential and HPA-binding during the study (22) . Forthe prognosis, the status of the lymph node is most important i.e., metastases are present in the local breast draining lymph nodes. The ability of the metastatic cells to bind HPA set a positive result as HPA-binding glycoconjugates are also found in most brain metastasis (23) and a similar correlation between the occurrence of metastatic tumor cells in local lymph nodes and HPA-binding of the primary tumorwas found for colorectal cancer. This particular feature of PHA was not found with other lectins (24). HPA-binding shows similarities with the result of the Duke's classification that also uses involvement of lymph node status as a risk assessment factor (25).
Several groups propose HPA as prognostic lectin for human breast cancer (26 -28) or at least of limited prognostic value (29, 30) , but it was not accepted widely (31 -33 From above studies the inference drawn is amazing that receptors for HPA are expressed in both the normal lactating breast and breast cancers that are metastasized to the local lymph node but not in those that do not metastasize. In the normal lactating breast HPA-binding was confined to the apical part tissue epithelium. SDS-PAGE and Westeming of human milk fat globule membrane protein revealed that only a limited number of glycoproteins react HPA (40) . There is an interindividual variation in the number of HPA-positive bands in SDS-PAGE, but recent data reveal maximum number of six bands (40) . Later studies have shown that in human HPA-positive breast cancer cell lines (MCF7 and T47D) expressing metastatic abilities in immmunologically suppressed animals (SCID mice), almost all glycoproteins are HPA-positive. Thus, a simple overexpression of one or all of the HPA-positive glycoprotein of milk fat globule membrane is not an expression for the fact that HPA-positive breast cancer is metastatic (unpublished data, Schumacher U) and that the glycosylation of cell membrane proteins has changed.
The particular HPA-binding glycoconjugates responsible for metastasis in breast cancer cells is not yet known (41).
The HPA-binding and breast cancer metastasis studies were based on long-term survival time. In short term survival studies, Wheat germ agglutinin (WGA), Lotus tetragonolobus agglutinin (LTA), Peanut agglutinin (PNA) and Ulex europaeus-I agglutinin (UAE-1) gave no further prognostic information than that already provided by histology (42) .
Transformed mammary tissues were also studj, ed for the specificity. Altered carbohydrate-binding patterns were investigated into transformed mammary tissues when treated with Isoform-1 from Cratylia mollis lectin (Cra Iso-1) utilizing histochemical techniques. This assay with Cra Iso-1 indicates a possible utilization of the lectin to characterize normal and transformed cells (43).
Colorectal cancer specific lectins
PNA is the most widely used lectin in colon cancer studies, but the detection depends largely on the sensitivity of the method used. A sequential progression in case of metastatic adenoma follows the following path: Human mannose-binding lectin (MBL) preferentially binds to some human colon adenocarcinoma cell lines (Colo205, Colo201, and DLD-1) expressing high amount of Lewis A and Lewis B antigens. This binding was analyzed by flow cytometry using specific antibodies against MBL and was found to be sugar specific and calcium dependent (46) .
In normal mucosa and adenocarcinoma samples from 43 colorectal cancer patients, the expression of different sialoglycoconjugates and fucoglycoconjugates was investigated by using specific lectins and applying semiquantitative analysis. A significant increase in the staining with Sambucus nigra lectin (SNA-1), which binds to alpha (2,6)-linked sialic acid residues, was detected in the epithelial cells as well as in the mucins from tumors. The intensity of staining with SNA-1 could be a valid parameter for predicting recurrence in colorectal cancer (47) . There are almost always identical lectin binding patterns between the primary tumors and local recurrences indicating that these may develop from remnant cells of the primary tumor left after surgery. The frequency of high-grade dysplasia was significantly greater in older patients and in samples with UEA-I positivity was worked out without neuraminidase pretreatment. UEA-Ireactive adenomas were generally characterized by high cell proliferation rates. A statistical model based on patient's age and UEA-I binding without neuraminidase treatment can generally predict grade of dysplasia in 83% of adenomas and particularly high-grade dysplasia in up to 93% of adenomas. So, such a model may be potentially useful for the early detection of neoplasia, for instance in exfoliative cells from the large intestine (48).
Hepatocellular (hepatopancreatic) carcinoma specific lectins
For the screening and prognosis of pancreatic carcinoma several investigators proposed the histochemical use of the PNA lectin. The parameter for the selection of PNA was due to an increased intensity in PNA-binding of secreted mucins in the pancreatic carcinoma.
The analysis of PNA-positive mucins was later refined by carbohydrate analysis of the P, NA-positive glycoproteins detected in the sera of cancer patients (49) . Furthermore, despite the non-binding of SBA by normal ductal epithelium, cancer cell lines, derived from pancreatic cancer (49) , showed a positive reaction with this lectin.
Detection of lectin-binding with Bauhinia purpurea agglutinin (BPA) or Vicia villosa agglutinin (VVA) in addition to PNA on cancer-associated mucins from patients with pancreatic and gastdc cancer has been considered a useful approach in the diagnosis of pancreatic cancer (50, 51) . Changes in glycosylation of normal pancreas during malignant transformation are not limited to mucin alone but also found in the glycan side chain of gammaglutamyltranspeptidase (52) .
Aleuria aurantia lectin (AAL) was invesgated in concern with liver cirrhosis (LC) and hepatocellular carcinoma. In liver cirrhosis (LC) and hepatocellular carcinoma Aleuria aurantia lectin (AAL)-reactive serum cholinesterase (chE) activity increases. This reactivity is used to discriminate liver cirrhosis from chronic hepatitis (53) .
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The long-term prognosis of hepatocellular carcinoma is predicted utilizing blood concentration levels of alpha-fetoprotein like the Lens culinaris agglutininreactive fraction (AFP-L3) as the useful markers. AFP-L3 is a positive indicator for small advanced hepatocellular carcinoma (54) .
Elevated serum levels of Tricosanthes japonica agglutinin-1 (TJA-1)-binding alkaline phosphatase (ALP) in serum were higher in cases of liver cirrhosis and hepatocellular carcinoma compared with chronic heptitis. This analysis is clinically useful for differentiating liver cirrhosis from chronic hepatitis and that altered sugar chain expression in ALP (55).
Genitourinary tract cancer specific lectins
Some lectins can be used to investigate the carbohydrate composition of transitional cell carcinoma and thus can be considered as markers of differentiation. Differentiation of tumors of urothelium from the normal tissues can thus be investigated using lectins. Lectins like Ricinus communis agglutinin (RCA-120), Wheat germ agglutinin (WGA), Griffonia simph'cifolia agglutinin (GSA-II) can be bound by all urothelial cell in the normal tissue in large amounts, while some lectins like PNA, Con A, DBA and SBA show only slight binding. Other lectins, such as Maclura pomifera agglutinin (MPA), UEA-I, GSA-I and DBA show an increased binding from basal to superficial cell layers (56) .
Blood group related carbohydrate antigen expression, which is detected by several specifi(: lectins, has been used as a predictive parameter in these tumors. Indeed using cell suspensions from transitional cell carcinoma, aneuploid cells bound PNA more extensively and were less reactive with WGA than diploid cell population (57) . Using tissue sections and comparing the classical markers of prognosis (aneuploidy and invasion) these changes correlated better with the loss of WGA-binding than the reduction in the PNA-binding (58), the latter have been characterized and found to be different to that of the blood group T-antigen (59).
Later, considering decrease in lectin binding during malignant progression as a parameter, several other lectins such as Vicia faba agglutinin (VFA), Lens cu/inaris agglutinin (LCA), PNA, WGA, Griffonia simp/icifo/ia agglutinin (GSA-II), So/anum tuberosum agglutinin (STA), DBA and HPA were studied (60) .
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But, with HPA as an exception, no binding sites were detected for other lectins (61).
Purified galactoside-specific lectin Viscum a/bum L. (VAA) was investigated as a major biological response modifier in the low dose range. Its effect on N-butyl-N-(4-hydroxybutyl)-nitrosamine(BBN)-induced carcinogenesis in the udnary bladder of rats. But it seems highly unlikely that adjuvant treatment with VAA might favorably influence bladder cancer in patients by immunological effector mechanisms (62).
Prostate cancer specific lectin
In case of prostate carcinoma (PCA), Soya bean agglutinin (SBA) was found to distinguish between benign and malignant cells by binding only to the latter (63) . Interestingly, later studies show a negative result for this binding (64, 65) .
In addition to the primary tumors, bone metastases derived from prostate adenocarcinoma have been studied and the remarkable result of the investigation was that HPA expression was more common in cases with metastases in the bone or other organs (66) . Studies on endometdal carcinoma show UEA-I and PNA to be useful indicators (67).
The asparagines (N)-Iinked sugar-chain structures of prostate-specific antigen (PSA) are altered in PCA and this may serve as diagnostic tool. This altered state can be investigated by passing the amounts of PSA through columns of Con A, PHA-E4 and PHA-L4. These amounts of PSA were significantly increased for PCA-dedved PSA. It was proposed that the sugar moiety structure of PSA, which is increased in PCA, is a multiantennary complex type with branched N-acetylglucosamine beta (1->4) mannose (68).
Lung cancer specific lectins
Lung cancer cases with reference to any specific lectin are not yet worked out widely. Recent studies show 159 cases of lung cancer that were investigated for their capacity to bind Viscum album L. (VAA) and galectin-1 and for Lewis antigen reactivity (69) . Approximately 70% of all tumors exhibited moderate to strong binding capacity for VAA. Adenocarcinomas and branchioalveolar carcinomas were more frequently labeled than squamous carcinomas. No correlation between VAAbinding capacity and survival was observed, whereas expression of galectin-1 binding sites revealed a better prognosis than those lacking binding sites or showing a weak reactivity (p=0.0257 log rank test or Kaplan-Meier statistics) (69) .
OTHER DISEASED TISSUES AND PROGNOSTIC LECTINS:
Varieties of other malignant tissues were also studied taking lectins into consideration to characterize the glycoconjugate content. Cepaea hortensis agglutinin (CHA-I) binds to O-glycosidically linked sialic acids with a characterized specificity. Thus CHA-I acts as a useful tool for detecting Oglycosidically linked sialic acid in formalin fixed tissues, and is a potentially powerful tool for the isolation and characterization of unknown sialomucin in normal and eventually in diseased tissues (70) .
THE GALECTIN FAMILY OF PROTEINS AND METAGENESIS:
The galectins are a family of proteins that includes calcium independent galactoside binding lectins with the beta-strand topology of the jelly-roll and are distributed widely in all living organisms (71) . This family has been implicated in many essential functions including development, differentiation, cellcell adhesion, cell-matrix interaction, growth regulation, apoptosis, RNA splicing, and tumor metastasis (72) . The functional versatility of galectin family explains the current interest in monitoring their expression in cancer research (71) . Their contribution to human carcinogenesis has been suggested from experimental studies. In clinical research, they could be used as a differentiation markers, particularly in thyroid carcinomas and in certain lymphomas (73) . Overexpression of one of the galectin, Galectin-7, is found to be associated with the apoptotic process in UVB-induced sunburn keratinocytes (74) . This galectin is a betagalactoside binding protein specifically expressed in stratified epithelia and notably in epidermis, but barely detectable in epidermal tumors and absent from squamous carcinoma cell lines. Further studies over this lectin of 14 kD molecular weight, show that it is a marker of all types of stratified epithelia (75) . Another galectin, Galectin-1 an endogenous lectin, possesses galactose specific surface binding sites (69).
The isolation of Prostate Carcinoma Tumor Antigen-I (PCTA-I), a cDNA closely related to rat and human Galectin-8, as a surface marker associated with prostate cancer was achieved. It appears that PCTA-I expression is almost ubiquitous in normal human tissues and could alter in specific context such as transformation and metastasis (76) . Galectin-8 is also reported to be a physiological modulator of cell adhesion. When immobilized, it functions as a matrix protein equipotent to fibronectin in promoting cell adhesion by ligation and clustering of cell surface integdn receptors (77) .
Tandem-repeat-type Galectin-9 and its (probable) allelic variant, ecalectin (a potent eosinophil chemoattractant) are human leukocyte product. Their mRNA is expressed in 17 oP21 human colorectal cancer cell lines (71) . This analysis identified the insertion of a single nucleotide into the coding sequence generating a frame-shift mutation, an event not so far reported for any other galectin. Thus mRNA for galectin-9-isoform or ecalectin is present in established human colon cancer cell lines (71). 
